Diagnosed with Cancer? Your two greatest challenges are understanding cancer and understanding possible side effects from chemo and radiation. Knowledge is Power!
Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
- You are here:
- Home »
- Blog »
- Lung Cancer »
- Lung Cancer and Astragalus?
Lung Cancer and Astragalus?
Lung cancer and astragalus? Living with my own incurable blood cancer, multiple myeloma, as well as many treatment-induced side effects, my lament is “I wish I knew then what I know now.” I say this because:
- Conventional cancer diagnostic testing, therapies, and support have come a long way-
- Evidence-based non-conventional treatments have also come a long way-
This is especially true for integrative therapies such as astragalus. According to the research linked below, astragulus can potentially enhance the efficacy of conventional lung cancer therapies while reducing their negative side effects.
Potential Benefits in Lung Cancer Treatment
Studies indicate several potential benefits when astragalus (specifically its active ingredient, Astragalus polysaccharide or APS) is used alongside standard treatments for non-small cell lung cancer (NSCLC):
- Improved Efficacy: Meta-analyses suggest that adding astragalus-based medicine to platinum-based chemotherapy may improve tumor response rates and patient survival at 12 and 24 months compared to chemotherapy alone.
- Reduced Toxicity: It may help alleviate severe side effects of chemotherapy and radiation, such as a reduction in white blood cell counts, nausea, vomiting, and radiation pneumonitis (lung inflammation).
- Enhanced Immune Function: Astragalus has been shown to have immunomodulatory effects, potentially stimulating the activity of macrophages and natural killer (NK) cells, which play a role in the body’s anti-tumor response.
- Alleviated Cancer-Related Fatigue: Clinical studies have explored its effectiveness in reducing cancer-related fatigue and improving the overall quality of life for patients.
- Inhibition of Metastasis: Preclinical studies in animal models suggest that APS might help inhibit the formation of the “premetastatic niche,” a process involved in tumor spread to the lungs.
Astragalus Benefits
Important Considerations
While the results are promising, medical professionals emphasize important caveats:
- Adjunct, Not Cure: Astragalus is primarily explored as a complementary treatment to enhance conventional therapies, not a replacement.
- Study Quality: Many of the studies conducted so far have been of low methodological quality, and better-designed, large-scale clinical trials are needed to confirm the exact benefits and safety.
- Consult a Doctor: As with any supplement, it is crucial to consult with your oncology team before using astragalus to ensure it does not interact with your specific cancer treatment plan or cause allergic reactions.
Have you been diagnosed with lung cancer? What stage? What therapies have you had or are considering? Scroll down the page, post a question or comment, and I will reply to you ASAP.
Hang in there,
David Emerson
- Cancer Survivor
- Cancer Coach
- Director PeopleBeatingCancer
Astragalus membranaceus: A Review of Its Antitumor Effects on Non-Small Cell Lung Cancer
Abstract: The rising global morbidity and mortality rates of non-small cell lung cancer (NSCLC) underscore the urgent need for more effective treatments. Current therapeutic modalities—including surgery, radiotherapy, chemotherapy, and targeted therapy—face several limitations.
Recently, Astragalus membranaceus, a traditional Chinese medicine (TCM), has captured significant attention due to its broad pharmacological properties, such as immune regulation, anti-inflammatory effects, and the modulation of reactive oxygen species (ROS) and enzyme activities.
This review delivers a comprehensive summary of the most recent advancements and ongoing applications of Astragalus membranaceus in NSCLC treatment, underlining its potential for integration into existing treatment protocols.
It also highlights essential areas for future research, including the elucidation of its molecular mechanisms, optimization of dosage and administration, and evaluation of its efficacy and safety alongside standard therapies, all of which could potentially improve therapeutic outcomes for NSCLC patients…
Conclusion and Future Perspectives
This review has comprehensively explored the promising antitumor properties of Astragalus membranaceus in the context of NSCLC. With its diverse pharmacological effects, including the modulation of immune responses, induction of apoptosis, inhibition of cell proliferation, and enhancement of chemotherapy sensitivity, Astragalus membranaceus presents a valuable adjunct to conventional cancer therapies. However, despite these encouraging findings, several gaps remain in the translation of preclinical results into clinical practice.
To better integrate Astragalus membranaceus into clinical settings for the treatment of NSCLC, future research should prioritize several key areas. First, robust, large-scale clinical trials are crucial to validate its efficacy and safety, focusing on determining optimal dosing regimens and identifying potential interactions with standard chemotherapy agents.
Additionally, although significant progress has been made in understanding the biological activities of Astragalus membranaceus, the detailed molecular mechanisms behind its antitumor effects still need further elucidation, which could reveal new therapeutic targets.
Another critical area of research is investigating how Astragalus membranaceus can overcome or prevent resistance to existing therapies, a major hurdle in NSCLC treatment.
Finally, considering its benefits on patient well-being and side effect management, further studies should also explore its impact on the quality of life, particularly in palliative care settings, to fully assess its potential as a supportive treatment option.
By addressing these research gaps, Astragalus membranaceus could be better positioned as a clinically viable option for NSCLC treatment, potentially improving patient outcomes and expanding the arsenal against this challenging disease.
Lung cancer and astragalus Lung cancer and astragalus Lung cancer and astragalus